These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31486887)

  • 61. The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma.
    Zanotti KM; Belinson JL; Kennedy AW; Webster KD; Markman M
    Gynecol Oncol; 1999 Aug; 74(2):272-7. PubMed ID: 10419744
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial.
    Rouzier R; Gouy S; Selle F; Lambaudie E; Floquet A; Fourchotte V; Pomel C; Colombo PE; Kalbacher E; Martin-Francoise S; Fauvet R; Follana P; Lesoin A; Lecuru F; Ghazi Y; Dupin J; Chereau E; Zohar S; Cottu P; Joly F
    Eur J Cancer; 2017 Jan; 70():133-142. PubMed ID: 27914243
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Short-term outcomes and prognosis of palliative surgery for malignant bowel obstruction caused by peritoneal metastasis of colorectal cancer].
    Chen PJ; Wang L; Chen N; Lu XY; Wang HS; He X; Wang Z; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Nov; 22(11):1051-1057. PubMed ID: 31770836
    [No Abstract]   [Full Text] [Related]  

  • 64. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.
    Manning-Geist BL; Hicks-Courant K; Gockley AA; Clark RM; Del Carmen MG; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
    Am J Obstet Gynecol; 2019 Oct; 221(4):326.e1-326.e7. PubMed ID: 31082382
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An exceptional evolution of primary peritoneal serous carcinoma.
    Ben Kridis W; Sghaier S; Toumi N; Khanfir A; Daoud J; Frikha M
    Acta Clin Belg; 2017 Dec; 72(6):439-442. PubMed ID: 28271744
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Optimal cytoreduction in advanced ovarian cancer treated with dose-dense paclitaxel and carboplatin followed by interval surgery at the Peruvian National Institute of Neoplastic Diseases].
    Alcarraz C; Muñiz J; Mas L; Olivera M; Morante Z; Alvarez M; Mantilla R; Araujo J; Pinto J
    Rev Peru Med Exp Salud Publica; 2018; 35(1):46-54. PubMed ID: 29924276
    [TBL] [Abstract][Full Text] [Related]  

  • 67. High-grade primary peritoneal serous papillary carcinoma with a wide differential diagnosis: a diagnostic challenge.
    Gilani S; Tashjian R; Fathallah L
    Pathologica; 2012 Dec; 104(6):442-5. PubMed ID: 23547430
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Longitudinal CA125 detection of sporadic papillary serous carcinoma of the peritoneum.
    Skates S; Troiano R; Knapp RC
    Int J Gynecol Cancer; 2003; 13(5):693-6. PubMed ID: 14675358
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness.
    da Costa Miranda V; de Souza Fêde ÂB; Dos Anjos CH; da Silva JR; Sanchez FB; da Silva Bessa LR; de Paula Carvalho J; Filho EA; de Freitas D; Del Pilar Estevez Diz M
    Gynecol Oncol; 2014 Feb; 132(2):287-91. PubMed ID: 24333355
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum.
    Look M; Chang D; Sugarbaker PH
    Int J Gynecol Cancer; 2003; 13(6):764-70. PubMed ID: 14675312
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prolonged symptom-free survival in a patient with persistent primary peritoneal carcinoma and a rising CA-125: a note of caution.
    Markman M
    Gynecol Oncol; 2001 Jun; 81(3):509-11. PubMed ID: 11371148
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube, or primary peritoneal carcinomas.
    Ebata T; Yunokawa M; Bun S; Shimomura A; Shimoi T; Kodaira M; Yonemori K; Shimizu C; Fujiwara Y; Kato T; Tamura K
    Cancer Chemother Pharmacol; 2016 Dec; 78(6):1283-1288. PubMed ID: 27832327
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Extraovarian peritoneal serous papillary carcinoma mimicking colonic obstruction.
    Theodosopoulos T; Marinis A; Yiallourou A; Dafnios N; Kondi-Pafiti A; Vassiliou I; Smyrniotis V; Karapanos K
    Eur J Gynaecol Oncol; 2008; 29(5):502-4. PubMed ID: 19051822
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Follow-up of ovarian and primary peritoneal carcinoma: the value of physical examination in patients with pretreatment elevated CA125 levels.
    Menczer J; Chetrit A; Sadetzki S; Golan A; Levy T
    Gynecol Oncol; 2006 Oct; 103(1):137-40. PubMed ID: 16564077
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Primary debulking surgery versus neo-adjuvant chemotherapy in stage III/IV ovarian cancer: Comparison of perioperative morbidity and survival data in Pakistani women.
    Chishti U; Aziz AB
    J Pak Med Assoc; 2015 Mar; 65(3):306-9. PubMed ID: 25933567
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [A Case of Splenic Metastasis from Serous Surface Papillary Carcinoma of the Peritoneum Treated by Laparoscopic Splenectomy].
    Kim Y; Hata T; Ogino T; Hoshino H; Kawada J; Okano M; Okuyama M; Yokoi T; Yamasaki M; Tsujinaka T
    Gan To Kagaku Ryoho; 2018 Apr; 45(4):697-699. PubMed ID: 29650839
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serous papillary peritoneal carcinoma: unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review.
    Pentheroudakis G; Pavlidis N
    Crit Rev Oncol Hematol; 2010 Jul; 75(1):27-42. PubMed ID: 19897383
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study.
    Luyckx M; Leblanc E; Filleron T; Morice P; Darai E; Classe JM; Ferron G; Stoeckle E; Pomel C; Vinet B; Chereau E; Bergzoll C; Querleu D
    Int J Gynecol Cancer; 2012 Oct; 22(8):1337-43. PubMed ID: 22964527
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution's Experience During Two Decades.
    Ihemelandu C; Sugarbaker PH
    Ann Surg Oncol; 2017 Apr; 24(4):898-905. PubMed ID: 27878480
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognosis for advanced-stage primary peritoneal serous papillary carcinoma and serous ovarian cancer in Taiwan.
    Chao KC; Chen YJ; Juang CM; Lau HY; Wen KC; Sung PL; Fang FY; Twu NF; Yen MS
    Taiwan J Obstet Gynecol; 2013 Mar; 52(1):81-4. PubMed ID: 23548224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.